Baker Tilly Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,714	Closed	-$239K	–	415
2023 Q4	$239K	Buy	25,714 +523	+2%	+$3.6K	0.04%	419
2023 Q3	$165K	Sell	25,191 -33	-0.1%	-$263	0.03%	443
2023 Q2	$205K	Buy	25,224 +15,224	+152%	+$130K	0.02%	521
2023 Q1	$85.7K	Hold	10,000	–	–	0.01%	536
2022 Q4	$92.6K	Hold	10,000	–	–	0.01%	521
2022 Q3	$103K	Hold	10,000	–	–	0.01%	492
2022 Q2	$100K	Hold	10,000	–	–	0.01%	481
2022 Q1	$123K	Hold	10,000	–	–	0.01%	508
2021 Q4	$173K	Hold	10,000	–	–	0.02%	514
2021 Q3	$180K	Hold	10,000	–	–	0.02%	493
2021 Q2	$229K	Hold	10,000	–	–	0.04%	452
2021 Q1	$150K	Sell	10,000 -10,000	-50%	-$109K	0.03%	456
2020 Q4	$108K	Buy	+20,000	New	+$105K	0.03%	332